ELC 13th Annual Scrubs Party March 28 2026 raises over 500000 for Pediatric Neurotrauma Lab to support pediatric TBI research at Children's Healthcare of Atlanta GA.
Dr. Reisner presents at EANS webinar on neuromonitoring in children with traumatic brain injury. Topic covers the role of biomarkers in monitoring children with TBI.
Holland Carlton had a brain tumor removed by Dr. Reisner at Children's in 2015. She now works alongside the care team that saved her life. Read her incredible story.
Dr. Blackwell attended the inaugural meeting of the Paediatric Research for the Future of Children in Geneva, Switzerland. The forum has 5 main themes: Precision Medicine and Novel Therapies in Paediatrics, Big Data in Paediatric Research, Child Mental Health and Development, Early Life Determinants of Health and Disease, and Promoting Global Paediatric Research and Paediatric Clinician Scientists Dr. Blackwell presented Transforming Care for Pediatric Concussion: A Focus on Behavioral and Emotional Outcomes. She served as a speaker for the Child Mental Health and Development session alongside Dr. Constantino, Chief of Behavioral and Mental Health at CHOA.
The Pediatric Neurocritical Care Research Group (PNCRG) focuses on advancing knowledge to optimize neurological outcomes in critically ill children by performing clinical and preclinical studies, supporting education, developing, and promoting best practices, and promoting advocacy. Dr. Reisner and Dr. Fainberg had the pleasure of presenting Biomarkers in Traumatic Brain Injuries in Children at a virtual meeting for PNCRG.
Dr. Reisner attended European Society for Pediatric Neurosurgery conference in Rome, presenting on pediatric TBI biomarkers and hydrocephalus. Visited Meyer Hospital
Dr. Reisner discusses biomarker research at Children's to improve TBI outcomes. Features Nellie's story and neurotrauma care advances for children.
Post Tags:
Emerging Leaders for Children's hosts 13th Annual Scrubs Party March 28, 2026 benefiting Pediatric Neurotrauma Lab to improve pediatric TBI treatment.
Dr. Jacob Lepard received Best Podium Presentation at the 51st ISPN Meeting in Lyon for his TBI biomarker research.
Dr. Reisner attended the 2024 International Conference on Recent Advances in Neurotraumatology in Jaipur, India, presenting on post-traumatic aneurysms and osteopontin biomarkers while leading discussions on neurotrauma and road safety as WFNS Neurotrauma Chair.
